Year: 2025

Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders

Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership

Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populationsFDA clearance of IND application triggered a US$...

Homecare Homebase Honors 2025 Customer Award Winners and Home Care Aide Scholarship Recipients Advancing Excellence in Home-Based Care

HCHB recognizes standout customers driving excellence and innovation, alongside this year's scholarship recipients, in support of workforce growth and advancement...

error: Content is protected !!